Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
2023-06-29 11:46:45
Reference is made to the annual general meeting in Nordic Nanovector ASA on 28
June 2023 and the approval of a transaction whereby Nordic Nanovector will
acquire all outstanding shares in Thor Medical AS against issuance of new shares
in Nordic Nanovector.
Roht Invest AS has previously agreed to sell its shares in Thor Medical against
receiving 15,994,640 shares in Nordic Nanovector subject to the approval of the
transaction by the annual general meeting. Pursuant to the agreement, Roht
Invest will upon subscription and delivery of shares as resolved by the general
meeting of Nordic Nanovector own a total of 15,994,640 shares in Nordic
Nanovector, corresponding to approximately 6.85% of the share capital and votes
in the Company.
The ownership has been calculated on the assumption that a share capital
increase of NOK 146,841 related to board compensation and the share capital
increase of NOK 23,353,900.60 related to the acquisition of Thor Medical is
completed, resulting in a share capital in Nordic Nanovector of NOK
46,707,801.20 divided on 233,539,006 shares.
This disclosure is made pursuant to section 4-2 of the Norwegian Securities
Trading Act.